Kogan & DiSalvo Personal Injury Law made a donation to our featured teachers of the week.CBS12 News’ next “Teacher Feature” ...
Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced the first patient has been dosed in the Phase 1/2 study evaluating CRN09682 in patients ...